What type of echocardiogram (echo) should be ordered for a new diagnosis of atrial flutter?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Echocardiographic Evaluation for New Atrial Flutter

For a new diagnosis of atrial flutter, a transthoracic echocardiogram (TTE) should be ordered as the initial imaging test, with transesophageal echocardiogram (TEE) reserved for patients requiring cardioversion who have not been adequately anticoagulated. 1

Initial Evaluation with Transthoracic Echocardiography (TTE)

TTE is the first-line imaging modality for patients with newly diagnosed atrial flutter for several important reasons:

  • Provides essential assessment of cardiac structure and function that guides management decisions and helps determine the underlying cause 1
  • Evaluates left atrial and right atrial size, which are important predictors of arrhythmia recurrence 1
  • Assesses left ventricular size and function, which influence treatment decisions and prognosis 1
  • Identifies valvular heart disease that may be contributing to or resulting from the arrhythmia 1
  • Detects structural heart disease that may increase thromboembolic risk 1
  • Screens for conditions that may contraindicate certain treatments 1

When to Consider Transesophageal Echocardiography (TEE)

TEE should be considered in specific clinical scenarios:

  • Prior to cardioversion in patients with atrial flutter lasting >48 hours who have not been adequately anticoagulated 1, 2
  • When TTE images are suboptimal or non-diagnostic 1
  • To exclude left atrial appendage thrombus before cardioversion 2, 3
  • When there is suspicion of intracardiac thrombi not visualized on TTE 4
  • In patients with congenital heart disease and atrial flutter, who have a higher risk of atrial thrombi 5

Key Components of Echocardiographic Assessment

The echocardiographic evaluation should include:

  • Left atrial size and volume assessment 1
  • Left ventricular size, wall thickness, and systolic function 1
  • Right ventricular size and function 1
  • Valvular structure and function (stenosis or regurgitation) 1
  • Assessment for structural heart disease that may contribute to atrial flutter 1
  • Estimation of pulmonary artery pressure 1
  • Evaluation for intracardiac thrombi (though TTE has limited sensitivity) 1

Important Considerations and Pitfalls

  • TTE has limited sensitivity for detecting left atrial appendage thrombi compared to TEE 4
  • A normal TTE in a patient with sinus rhythm has a high negative predictive value for left atrial appendage thrombi 4
  • TEE-guided cardioversion without prior anticoagulation is not recommended despite the ability to exclude thrombi, as post-cardioversion thrombus formation remains a risk 3, 6
  • In patients with congenital heart disease and atrial flutter, TEE may be necessary even with non-fibrillation atrial arrhythmias due to higher thrombus risk 5
  • Contrast echocardiography may be useful in cases with poor endocardial definition 1

Summary of Approach

  1. Order a standard transthoracic echocardiogram as the initial imaging test for all patients with newly diagnosed atrial flutter 1
  2. If cardioversion is planned and the patient has not been adequately anticoagulated for at least 3 weeks, order a TEE to exclude thrombus 1, 2
  3. Consider TEE if the TTE is technically limited or if there are specific concerns about thrombus that cannot be adequately assessed by TTE 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.